139 related articles for article (PubMed ID: 30515663)
1. Anti-RNP/Sm antibodies in patients with systemic lupus erythematosus and its role in thrombosis: a case-control study.
Zamora-Medina MDC; Hinojosa-Azaola A; Nuñez-Alvarez CA; Vargas-Ruiz AG; Romero-Diaz J
Clin Rheumatol; 2019 Mar; 38(3):885-893. PubMed ID: 30515663
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid antibodies and the risk of adverse pregnancy outcomes in patients with systemic lupus erythematosus: a systematic review and meta-analysis.
Huang J; Zhu Q; Wang B; Wang H; Xie Z; Zhu X; Zhao T; Yang Z
Expert Rev Clin Immunol; 2024 Jul; 20(7):793-801. PubMed ID: 38445835
[TBL] [Abstract][Full Text] [Related]
3. The persistence of anticardiolipin antibodies is associated with an increased risk of the presence of lupus anticoagulant and anti-beta2-glycoprotein I antibodies.
Neville C; Rauch J; Kassis J; Solymoss S; Joseph L; Belisle P; Subang R; Chang ER; Fortin PR
Rheumatology (Oxford); 2006 Sep; 45(9):1116-20. PubMed ID: 16510527
[TBL] [Abstract][Full Text] [Related]
4. Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?
Foret T; Dufrost V; Salomon Du Mont L; Costa P; Lefevre B; Lacolley P; Regnault V; Zuily S; Wahl D
Curr Rheumatol Rep; 2021 Jul; 23(8):65. PubMed ID: 34218350
[TBL] [Abstract][Full Text] [Related]
5. Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage.
Conti F; Alessandri C; Perricone C; Scrivo R; Rezai S; Ceccarelli F; Spinelli FR; Ortona E; Marianetti M; Mina C; Valesini G
PLoS One; 2012; 7(3):e33824. PubMed ID: 22461897
[TBL] [Abstract][Full Text] [Related]
6. Influenza vaccination can induce new-onset anticardiolipins but not β2-glycoprotein-I antibodies among patients with systemic lupus erythematosus.
Vista ES; Crowe SR; Thompson LF; Air GM; Robertson JM; Guthridge JM; James JA
Lupus; 2012 Feb; 21(2):168-74. PubMed ID: 22235049
[TBL] [Abstract][Full Text] [Related]
7. Are serum autoantibodies associated with brain changes in systemic lupus erythematosus? MRI data from the Leiden NP-SLE cohort.
Magro-Checa C; Kumar S; Ramiro S; Beaart-van de Voorde LJ; Eikenboom J; Ronen I; de Bresser J; van Buchem MA; Huizinga TW; Steup-Beekman GM
Lupus; 2019 Jan; 28(1):94-103. PubMed ID: 30526327
[TBL] [Abstract][Full Text] [Related]
8. Pattern of disease expression in SLE patients with antiphospholipid antibodies: data from Indian Systemic Lupus Erythematosus Inception cohort (INSPIRE).
Shobha V; Rajasekhar L; Manuel S; Nayana V; Kavadichanda C; Kounassegarane D; Mathew AJ; Gupta R; Rathi M; Ghosh P; Tripathy SR; Das B; Selvam S; Singh AK; Singh A; Jain A; Aggarwal A
Rheumatol Int; 2024 May; 44(5):819-829. PubMed ID: 38082159
[TBL] [Abstract][Full Text] [Related]
9. Anti-Nuclear Antibodies Patterns in Patients With Systemic Lupus Erythematosus and Their Correlation With Other Diagnostic Immunological Parameters.
Al-Mughales JA
Front Immunol; 2022; 13():850759. PubMed ID: 35359932
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus.
Hanly JG; Urowitz MB; Su L; Bae SC; Gordon C; Clarke A; Bernatsky S; Vasudevan A; Isenberg D; Rahman A; Wallace DJ; Fortin PR; Gladman D; Romero-Diaz J; Sanchez-Guerrero J; Dooley MA; Bruce I; Steinsson K; Khamashta M; Manzi S; Ramsey-Goldman R; Sturfelt G; Nived O; van Vollenhoven R; Ramos-Casals M; Aranow C; Mackay M; Kalunian K; Alarcón GS; Fessler BJ; Ruiz-Irastorza G; Petri M; Lim S; Kamen D; Peschken C; Farewell V; Thompson K; Theriault C; Merrill JT
Ann Rheum Dis; 2011 Oct; 70(10):1726-32. PubMed ID: 21893582
[TBL] [Abstract][Full Text] [Related]
11. Unveiling the Link Between Antiphospholipid Antibodies and Cognitive Dysfunction in the Almenara Lupus Cohort.
Velarde-Mejía Y; Gamboa-Cárdenas R; Zevallos F; Medina M; Rodriguez-Bellido Z; Pastor-Asurza C; Alarcón GS; Ugarte-Gil MF
J Clin Rheumatol; 2024 Mar; 30(2):41-45. PubMed ID: 38115180
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER).
Laíño-Piñeiro MC; Rúa-Figueroa I; Jiménez N; Lozano MJC; Martínez-Barrio J; Serrano B; Galindo-Izquierdo M; Nack A; Loricera J; Tomero-Muriel E; Ibáñez-Barceló M; Vázquez NM; Manrique-Arija S; Lorenzo NA; Narváez J; Rosas J; Menor-Almagro R; Martínez-Taboada VM; Aurrecoechea-Aguinaga E; Horcada L; Ruiz-Lucea E; Raya E; Toyos FJ; Expósito L; Vela P; Freire-González M; Moriano-Morales C; Bonilla-Hernán G; Ibáñez TC; Lozano-Rivas N; Moreno M; Andreu JL; Ubiaga CLI; Torrente-Segarra V; Valls E; Velloso-Feijoo ML; Alcázar JL; Pego-Reigosa JM
Semin Arthritis Rheum; 2023 Aug; 61():152232. PubMed ID: 37348350
[TBL] [Abstract][Full Text] [Related]
13. Insights into systemic lupus erythematosus: a retrospective observational study of clinical features, autoantibodies, and gender-related differences.
Adwan MH; Qasem U; Atawnah SY; Itmeizeh M; Hanbali R; Alsoofi NA; Jbara MA; AbuHelal A; Alnaimat F
Rheumatol Int; 2024 Jul; 44(7):1255-1263. PubMed ID: 38717538
[TBL] [Abstract][Full Text] [Related]
14. DIAGNOSTIC VALUE OF LABORATORY MARKERS OF SYNTROPIC LESIONS OF THE CIRCULATORY SYSTEM ORGANS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.
Kobak L; Abrahamovych O; Abrahamovych U; Maksymuk A; Ivanochko R
Georgian Med News; 2023; (340-341):159-164. PubMed ID: 37805891
[TBL] [Abstract][Full Text] [Related]
15. Low CD4 + T cell count is related to specific anti-nuclear antibodies, IFNα protein positivity and disease activity in systemic lupus erythematosus pregnancy.
Torell A; Stockfelt M; Blennow K; Zetterberg H; Akhter T; Leonard D; Rönnblom L; Pihl S; Saleh M; Sjöwall C; Strevens H; Jönsen A; Bengtsson AA; Trysberg E; Majczuk Sennström M; Zickert A; Svenungsson E; Gunnarsson I; Bylund J; Jacobsson B; Rudin A; Lundell AC
Arthritis Res Ther; 2024 Mar; 26(1):65. PubMed ID: 38459582
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for cardiovascular diseases in patients with systemic lupus erythematosus: an umbrella review.
Katayama Y; Yanai R; Itaya T; Nagamine Y; Tanigawa K; Miyawaki Y
Clin Rheumatol; 2023 Nov; 42(11):2931-2941. PubMed ID: 37142864
[TBL] [Abstract][Full Text] [Related]
17. The association of an elevated Th/Ts ratio and lupus anticoagulant with symptomatic osteonecrosis in systemic lupus erythematosus patients.
Hou R; Lei J; Xue D; Jing Y; Mi L; Guo Q; Xu K; Zhang L
Front Immunol; 2024; 15():1288234. PubMed ID: 38384449
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of acquired and hereditary risk factors for the development of thromboembolism in patients with systemic lupus erythematosus.
Gürsoy V; Sadri S; Ermurat S
Blood Coagul Fibrinolysis; 2023 Dec; 34(8):478-486. PubMed ID: 37756208
[TBL] [Abstract][Full Text] [Related]
19. Immune thrombocytopenia in systemic lupus erythematosus: Prevalence, risk factors, and a novel predictive model for risk assessment.
Cornudella Lema J; Sánchez-González B; Carrión-Barberà I; Vázquez Montes de Oca S; García Pallarols F; Salman-Monte TC
Med Clin (Barc); 2024 May; 162(10):461-469. PubMed ID: 38383267
[TBL] [Abstract][Full Text] [Related]
20. Systemic lupus erythematosus and Raynaud's phenomenon.
Heimovski FE; Simioni JA; Skare TL
An Bras Dermatol; 2015; 90(6):837-40. PubMed ID: 26734864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
